Michael Sax
Impact in
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Pharmaceutical Practices and Patient Outcomes 6
-
- Health Systems, Economic Evaluations, Quality of Life 6
- Pharmaceutical Economics and Policy 3
- Co-authors
- David R. Gray (3 shared papers)Susan M. Garabedian‐Ruffalo (1 shared paper)Alexander Swarbrick (2 shared papers)Ruth Freeman (2 shared papers)Vivek Mittal (2 shared papers)Albert S. Mellick (2 shared papers)Christopher Johns (1 shared paper)Nigel A.J. McMillan (1 shared paper)
- Journals
- American Journal of Health-System Pharmacy (1 paper)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)Oncotarget (1 paper)Cancer Research (1 paper)Drug Information Journal (1 paper)
- Partner nations
- United StatesAustralia
In The Last Decade
Michael Sax
13 papers receiving 317 citations
Peers
Comparison fields: 5 of 62
- Geriatrics and Gerontology 44
- Internal Medicine 39
- Family Practice 9
- Cancer Research 71
- Cardiology and Cardiovascular Medicine 75
Countries citing papers authored by Michael Sax
This map shows the geographic impact of Michael Sax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Sax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Sax more than expected).
Fields of papers citing papers by Michael Sax
This network shows the impact of papers produced by Michael Sax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Sax. The network helps show where Michael Sax may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Sax, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 111 | |
| 2 | 2012 | 104 | |
| 3 | 2016 | 30 | |
| 4 | 1987 | 24 | |
| 5 | 1993 | 20 | |
| 6 | Clinical pharmacists as allied health care providers to psychiatric patients. | 1979 | 19 |
| 7 | Effect of two cimetidine regimens on prothrombin time and warfarin pharmacokinetics during long-term warfarin therapy. | 1987 | 11 |
| 8 | 2005 | 5 | |
| 9 | 2019 | 3 | |
| 10 | 1996 | 1 | |
| 11 | 2005 | 1 | |
| 12 | The drug formulary decision-making process. | 1999 | 1 |
| 13 | 1999 | 1 | |
| 14 | 1979 | 0 |
About Michael Sax
Michael Sax is a scholar working on Geriatrics and Gerontology, Economics and Econometrics, Molecular Biology, Pharmacology and Cancer Research, having authored 14 papers that have together received 331 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmaceutical Economics and Policy (3 papers), Angiogenesis and VEGF in Cancer (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Patient Satisfaction in Healthcare (1 paper), Chemokine receptors and signaling (1 paper) and Biosimilars and Bioanalytical Methods (1 paper). The work is most often cited by research in Geriatrics and Gerontology (44 citations), Internal Medicine (39 citations), Family Practice (9 citations), Cancer Research (71 citations) and Cardiology and Cardiovascular Medicine (75 citations). Michael Sax has collaborated with scholars based in United States and Australia. Frequent co-authors include David R. Gray, Susan M. Garabedian‐Ruffalo, Alexander Swarbrick, Ruth Freeman, Vivek Mittal, Albert S. Mellick, Christopher Johns, Nigel A.J. McMillan, Jelena Vider and Vito Ferro. Their work appears in journals such as American Journal of Health-System Pharmacy, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Oncotarget, Cancer Research and Drug Information Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.